Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells by unknown
Microtubule Dependency of p34  ¢ac2 Inactivation 
and Mitotic Exit in Mammalian Cells 
Paul R. Andreassen and Robert L. Margolis 
Institut de Biologie Structurale, 38027 Grenoble, France 
Abstract.  The protein kinase inhibitor 2-aminopurine 
induces checkpoint override and mitotic exit in BHK 
cells which have been arrested in mitosis by inhibitors 
of microtubule function (Andreassen,  P. R.,  and R. L. 
Margolis.  1991. J.  Cell Sci.  100:299-310).  Mitotic 
exit is monitored by loss of MPM-2 antigen,  by the 
reformation of nuclei,  and by the extinction of p34  ~c2- 
dependent H1 kinase activity. 2-AP-induced inactiva- 
tion of p34  ~c2 and mitotic exit depend on the assembly 
state of microtubules.  During mitotic arrest generated 
by the microtubule assembly inhibitor nocodazole, the 
rate of mitotic exit induced by 2-AP decreases propor- 
tionally with increasing nocodazole concentrations.  At 
nocodazole concentrations of 0.12  #g/ml or greater, 
2-AP induces no apparent exit through 75 rain of 
treatment.  In contrast,  2-AP brings about a rapid exit 
(tit2 =  20 min)  from mitotic arrest by taxol, a drug 
which causes inappropriate overassembly of microtu- 
bules.  In control mitotic cells, p34  ~'2 localizes to 
kinetochores, centrosomes, and spindle microtubules. 
We find that efficient exit from mitosis occurs under 
conditions where p34  ~2 remains associated with cen- 
trosomal microtubules,  suggesting it must be present 
on these microtubules in order to be inactivated.  Mi- 
totic slippage, the natural  reentry of cells into G, dur- 
ing prolonged mitotic block, is also microtubule de- 
pendent.  At high nocodazole concentrations  slippage is 
prevented and mitotic arrest approaches  100%.  We 
conclude that essential components of the machinery 
for exit from mitosis are present on the mitotic spin- 
dle, and that normal mitotic exit thereby may be regu- 
lated by the microtubule assembly state. 
M 
ITOTIC checkpoints block progression through,  and 
exit from, mitosis if a functional  mitotic spindle 
is not present (Hartwell and Weinert,  1989; Mur- 
ray, 1992).  Such checkpoints,  whose function  is to assure 
that the cell does not exit mitosis until the genome has been 
properly  segregated,  can  be  subverted.  Saccharomyces 
cerevisiae  mutants  have been isolated that  fail to maintain 
mitotic arrest during exposure to benomyl (Hoyt  et al., 1991; 
Li and Murray,  1991), an inhibitor of microtubule assembly. 
Under restrictive  conditions,  these mutants  inactivate  the 
p34  ~2 kinase and progress forward  into G~ without divi- 
sion.  Similarly,  various cell types blocked in mitosis for a 
prolonged period with microtubule inhibitors  undergo "mi- 
totic slippage; which is a failure to maintain  their arrested 
state (Chamla  et al.,  1980; Kung et al.,  1990; Rieder and 
Palazzo,  1992). During mitotic slippage, CHO cells degrade 
cyclin  B and  downregulate  p34  cd~ kinase activity,  and re- 
sume interphase  and DNA replication  without first complet- 
ing chromosome segregation  or cell division (Kung et al., 
1990). 
We have previously shown that mammalian  cells can also 
be induced  to evade mitotic checkpoints  and  exit mitosis 
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prematurely when exposed to the protein kinase  inhibitor 
2-aminopurine  (2-AP)'  (Andreassen  and  Margolis,  1991, 
!992). Exposure of mammalian cells to 2-AP during mitotic 
arrest induces  the cells to exit mitosis without the comple- 
tion of late mitotic events such as chromosome segregation 
or cytokinesis (Andreassen  and Margolis,  1991). 
The p34  c~c2 kinase  is universally  required as the master 
control enzyme during mitosis in eukaryotes (Nurse, 1990; 
Norbury and Nurse,  1992). Its activity is regulated  during 
the cell  cycle,  and peaks at mitosis  (Draetta  and  Beach, 
1988; Gautier et al.,  1989).  Exit from mitosis requires the 
inactivation  of p34  cdc2 by the degradation  of the cyclin  B 
regulatory subunit (Murray et al., 1989; Ghiara et al., 1991; 
Gallant  and  Nigg,  1992)  and  the  dephosphorylation  of 
p34  ¢dc2 at thrl61  (Lorca et al.,  1992).  A  subpopulation  of 
p34  ~2 is localized  to the mitotic apparatus  during  mitosis 
(Bailly et al., 1989; Riabowol et al., 1989; Alfa et al., 1990; 
Rattner et al.,  1990). The localization  of p34  c~2 is probably 
important  to its function (Pines and Hunter,  1991), and may 
also be important to its regulation (Alfa et al., 1990; Kubiak 
et al.,  1993; Edgar et al.,  1994).  Likewise,  in the process 
of mitotic exit, localization  of p34  ~2 to the mitotic spindle 
could be important to its inactivation. 
1. Abbreviation used in this paper: 2-AP, 2-aminopurine. 
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checkpoint override induced by 2-AP.  Further,  we find that 
the level of microtubule assembly determines the capacity of 
BHK cells to evade mitotic checkpoints and exit from mito- 
sis inappropriately during treatment with 2-AP, and during 
natural mitotic slippage. Our results show that the major dis- 
tinction between 2-AP induced exit and mitotic slippage is 
that 2-AP greatly accelerates the escape from mitotic arrest. 
These results suggest that critical elements of the machinery 
for  the  inactivation  of p34  ~°2  are  dependent  on  microtu- 
bules in these cells. The linkage of the microtubule assembly 
state to the regulation of p34  c.2 kinase activity may consti- 
tute an inherent checkpoint mechanism that couples the loss 
of p34  ~c2 activity at the onset of anaphase with the capacity 
for  accurate  microtubule-dependent  chromosome  segre- 
gation. 
Materials and Methods 
Cell Culture and Synchronization 
BHK cells were cultured as monolayers in Dulbecco's Modified Eagle's 
Medium (GIBCO BRL, Paisley,  UK) supplemented with 10% fetal bovine 
serum (Hyclone, Logan, UT). Cells were maintained in a humid incubator 
at 370C  in a 5%  CO2 environment. 
1hxol and nocodazole were both obtained from Sigma Chemical Co. (St. 
Louis, MO) and were prepared as stock solutions in DMSO (5 mg/rnl taxol, 
1 mg/ml nocodazole) which were kept frozen until used. 
Immunofluorescence Microscopy 
BHK cells were grown on poly-lysine-coated coverslips for a minimum of 
16  h  before drug  treatment.  Except for  immunolocalization of p34  '~c2, 
cells were fixed with 2 % paraformaldehyde-PBS, permeabilized with 0.2 % 
Triton X-100 in PBS for 3 rain, and then processed with primary and sec- 
ondary  antibodies  as  described  previously  (Andreassen and Margolis, 
1991). Secondary antibodies, all from Cappel Laboratories (West Chester, 
PA),  included  FITC-conjugated  affinity  purified  goat  anti-human  IgG, 
anti-mouse IgG,  and  anti-rabbit IgG antibodies,  and Texas  Red  sheep 
anti-mouse IgG antibodies applied at 2.5 #g/ml. 
For immunolocalization of p34  ~¢2, cells were first extracted in microtu- 
bule stabilizing buffer: 45 mM Pipes, 45 mM Hepes, 10 mM EGTA, 5 mM 
MgC12, pH 6.9, also including 0.5% Triton X-100, for 90 s at 37°C (Bail- 
ley et al., 1989). Cells were then fixed 5 rain in methanol at -20°C, washed 
with PBS, and then incubated with primary and secondary antibodies. 
The following antibodies were used for indirect immmunofluorescence 
microscopy, MPM-2 mouse monoclonal antibody, a gift from Dr. P. N. Rao 
(University of Texas, M. D. Anderson Cancer Center, Houston, TX), was 
used as a 750-fold dilution of the ascites fluid. Anti-/~-tubulin  ascites anti- 
body from Sigma Chemical Co. (TUB 2.1) was used at a 400-fold dilution. 
Anti-centromere serum from a human patient with CREST Scleroderma, 
provided by Dr. Barbara Hamkaio (University of California at Irvine, Ir- 
vine, CA), was used at a 500-fold dilution. Antibodies generated in rabbits 
against amino acids 290-297 of human p34  cde2 (1419 and 1524) were sup- 
plied by Dr. David Litchfield (Manitoba Institute of  Cell Biology, Winnipeg, 
Canada).  These anti-p34 sera were used at a  1,000-fold  dilution for the 
crude sera and at 0.5 #g/ml for antibody affinity-purified against the antigen 
peptide (Litchfield et al.,  1991). 
For microscopy, coverslips were mounted as previously described (An- 
dreassen and Margolis,  1991). Samples were observed using a MRC-600 
Laser Scanning confocal apparatus (Bio-Rad Microscience Division, Herts, 
England). Photographs were taken on TMAX-100 film with a Polaroid CI- 
3000 film recorder. 
Histone H1 Kinase Assay 
BHK cells grown in tissue culture dishes were treated with taxol or nocoda- 
zole for 10 h, and a mitotic index of 'x,60%  was obtained. Cells were then 
placed in medium containing either taxol or nocodazole alone, or in taxol 
or nocodazole and 10 mM 2-AP. At the indicated timepoints cell extracts 
were prepared in lysis buffer, which was composed of: 50 mM Tris-HCl, 
pH 7.4,  250 mM NaCI, 5  mM EGTA, 0.1%  NP-40 (Draetta and Beach, 
1988),  and also containing 0.1 mM PMSF, 10 t~g/ml aprotinin,  10 #g/ml 
leupeptin, 60 mM/3-glyeerophosphate, 50 mM NaF, and 0.5 mM sodium 
vanadate. Cells were transferred to an Eppendorf tube (Brinkman Instru- 
ments, Westhury, NY) and kept on ice for 30 rain. Lysate supernatants were 
then collected by centrifugation at 13,000 g  for 5  min at 4"C. 
To preclear cell extracts of  proteins nonspecifically binding to Sepharose 
beads, 50 #1 of  each extract was incubated for 30 min at 4°C, with agitation, 
in a  1:1 slurry with protein A-Sepharose 4B beads (Sigma Chemical Co.) 
in lysis buffer.  40 #g of each cleared extract was then incubated with 4.0 
#g afffinity-purified antibody raised against the COOH terminus of p34  cdc2 
(Koff et  al.,  1991) for  1  h  at  40C  with  agitation.  50  #1  of protein 
A-Sepharose slurry was then added and the extract was further incubated 
for 1 h at 40C.  The resulting immune complex was washed three times in 
lysis buffer and one time with kinase buffer, composed of 50 mM Tris, pH 
7.4,  10  mM  MgCI2,  1 mM  ~  and 0.1  mg/ml BSA.  The pellet was 
resuspended  in  50  #1  of  kinase  buffer  containing  1  #g  histone  H1 
(Boehringer Mannheim Biochemicais, Indianapolis, IN) 30 #M ATE and 
5 #Ci of [,y.32p] ATP (Koff et al.,  1991). The HI kinase reaction was car- 
ried out for 30 min at 37"C and was terminaa~d  by the addition of sample 
buffer. Samples were then resolved by SDS-PAGE using 2% polyacrylamide 
gels (19:1 ratio of acrylamide to bis-acrylamide).  Autoradingraphs were 
prepared by exposure to Hyperfiim-MP (Amersham Corp.). 
Immunoblotting 
1.0/~g of BHK lysate, prepared as above, was resolved on 8% polyacryl- 
amide gels (30:0.8  ratio of acrylamide to bis-acrylamide) using a mini-gal 
apparatus (Bio-Rad Laboratories).; Electrophoretic transfer to nitrocellu- 
lose was performed according to Khyse-Andersen (1984).  After transfer, 
nitrocellulose sheets (Amersham Corp.) were blocked for 60 min with 5% 
nonfat milk in 25 mM Tris, pH 7.5, 150 mM NaCl, 0.05%  Tween 20 (TNT 
buffer). Blots were then washed twice for 10 min each, and then incubated 
overnight at RT with anti-p34 (1419)  antibody diluted 5,000-fold in TNT 
buffer. Blots were further processed by washing twice for 5 min with TNT 
buffer, 5 min with TNT buffer containing 0.5%  Tween 20,  and again for 
5 rain with TNT buffer (0.05 % Tween 20). HRP-conjugated goat anti-rabbit 
IgG secondary antibody (Tago, Burlingame, CA), diluted 7,500-fold in TNT 
buffer (0.05 % Tween 20), was applied for 1 h at room temperature. Blots 
were then washed in the same manner as for primary antibody incubation. 
Protein-antibody complex was detected by enhanced chemiluminescence 
(Amersham Corp.). 
Flow Cytometric Analysis 
Cells  were  collected by  trypsinization,  pooled  with  nonattached  cells, 
resuspended in PBS,  and fixed by addition of 90%  methanol at  -20"C 
(Schimenti  and  Jacobberger,  1992).  After  10  rain  fixation,  cells  were 
pelleted, and then resuspended and stored in PBS with 0.04% sodium azide. 
Mitotic cells were determined using MPM-2 antibody, by incubation for 1 h 
at 37 °C with MPM-2 antibody diluted 750-fold in PBS/0.05 % Tween 20/3 % 
BSA. After exposure to the antibody, cells were washed twice for 5 rain each 
with PBS, and incubated with FITC-conjugated goat anti-mouse IgG sec- 
ondary antibody 30 min at 37°C. Cells were then washed twice with PBS 
and resuspended in 4 mM sodium citrate, also containing 30 U/ml RNase A, 
0.1% Triton X-100, and 50 #g/ml propidium iodide for 10 min at 37°C. So- 
dium chloride was then added at 138 raM, and samples were kept on ice 
until analyzed (Andreassen and Margolis,  1992). 
Data were collected using a FACScan (Becton Dickinson &  Co., San 
Jose, CA) and results analyzed with LYSYS II software. For each sample, 
10,000  events were collected and aggregated cells were gated out. 
Results 
The Mitotic Exit Induced by 2-AP Is 
Microtubule Dependent 
We have previously shown that BHK cells, arrested in mito- 
sis with either 5 #g/ml taxol or 0.04/~g/ml nocodazole, can 
be induced by 2-AP to reenter interphase without completion 
of cell  division  (Andreassen  and  Margolis,  1992).  In our 
previous work, the parameters followed to determine reentry 
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Figure  1.  Exit  from mitosis  induced by 2-AP is more rapid  for 
taxol-arrested cells than for nocodazole-arrested  cells. BHK cells 
were synchronized in mitosis by treatment with either 5 #g/ml taxol 
or 0.04 txg/ml nocodazole. At t = 0 cells were given 10 mM 2-AP 
in addition to taxol or nocodazole, while controls were maintained 
in either taxol or nocodazole alone. Cells were fixed at timepoints 
and processed  for immunofluorescence  microscopy to determine 
the mitotic index. Cells were determined to be mitotic by the pres- 
ence of MPM-2 signal, which detects mitosis-specific  phosphory- 
lation epitopes (Davis et al., 1983). The mitotic index was further 
confirmed by a second assay of chromosome condensation,  using 
propidium iodide stain. All points represent the average of three in- 
dependent counts of  greater than 150 cells each. Standard deviation 
was less than 2.5%  of the ordinate value for all data points. 
into interphase were reformation of the nuclear lamin B bor- 
der,  and reconstitution of interphase  nuclei as detected by 
propidium iodide staining (Andreassen and Margolis, 1991). 
In the present study we further verify exit from mitosis by 
loss of reactivity with MPM-2 antibodies, which recognize 
mitosis-specific epitopes (Davis et al., 1983), and by the ex- 
tinction of p34  ~c2 H1  kinase activity. 
We have determined that the rate of exit is conditional on 
the method of mitotic arrest.  For example, the rate of exit 
is  more rapid for taxol-treated cells than for nocodazole- 
arrested cells (Fig.  1). Taxol arrests cells in mitosis with an 
inappropriately high level of microtubule assembly (Schiff 
and Horwitz, 1980), while nocodazole arrests cells by inter- 
feting with microtubule assembly (Jordan et al.,  1992). 
The rate of blockage in mitosis is not affected by the nature 
of the mitotic block. Thus, the mitotic indices resulting from 
arrest with taxol or nocodazole are indistinguishable after 
7.5 h of treatment. However, after addition of 2-AP, differ- 
ences in the mitotic indices rapidly become apparent.  Mi- 
totic exit is first detected in taxol-arrested cells by 15 min 
after the addition of 10 mM 2-AP, and half of the cells exit 
mitosis by 20 min. In contrast, cells arrested with 0.04 #g/ml 
nocodazole first display evidence of mitotic exit by 25 rain 
after the addition of 2-AP, and half the cells exit by 45 min. 
Control cells in the continuous presence of taxol or nocoda- 
zole alone do not show evidence of mitotic exit and the mi- 
totic index for these populations continues to increase during 
the course of the experiment. 
Data for analysis of the rate of mitotic exit were obtained 
by immunofluorescence microscopy, using MPM-2 antibod- 
ies. Mitotic cells, and not interphase cells, exhibit a bright 
and  distinct  MPM-2  signal,  as  shown  for a  taxol-treated 
population of BHK ceils (Fig. 2). Because of the brightness 
of the mitotic signal, one can rapidly discriminate between 
mitotic and interphase cells using this marker. The MPM-2 
signal disappears upon the addition of 2-AP to cells in taxol 
induced  mitotic arrest.  By this  criterion,  after 60 min of 
2-AP treatment taxol-treated cells have reentered interphase, 
Figure  2.  MPM-2  signal  is 
down regulated and nuclei re- 
form  during  mitotic  check- 
point  override  induced  by 
2-AP.  Mitotic  cells  that  ac- 
cumulate  during  treatment 
with  5  #g/ml  taxol  react 
strongly  with  MPM-2  anti- 
bodies (top left) and have con- 
densed  chromosomes  (top 
right),  in  contrast  to  inter- 
phase cells (as determined by 
propidium  iodide  staining  at 
right)  which display minimal 
MPM-2 signal. 60 min after 
addition  of 10 mM 2-AP to 
taxol-treated  ceils,  exit  from 
mitosis is apparent, as is made 
evident by the loss of MPM-2 
signal (bottom left) and the ap- 
pearance of micronuclei  (bot- 
tom right).  An exceptional cell 
that has remained in mitosis in 
the presence of taxol  +  2-AP 
is included in the field to dem- 
onstrate  that  MPM-2  signal 
does  not  diminish  with  this 
treatment until there is actual 
exit from mitosis. Bar, 10 #m. 
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Figure 3. Exit from mitosis induced by 2-AP occurs without cell division and results in quantitative down regulation of MPM-2 signal. 
Cell populations were analyzed for DNA content and MPM-2 antigen abundance by flow cytometry. Cells subjected to analysis included 
untreated cycling BHK cells (left), a population of mitotic cells obtained by 8-h treatment with 5 pg/ml taxol and harvested by selective 
detachment (middle) and a population of cells exposed to taxol  +  10 mM 2-AP for 60 min after selective detachment  of taxol treated 
mitotic ceils (right). All cell populations were analyzed for DNA content distributions, with data displayed in histogram form (A). Mitotic 
cells in taxol (middle) and post-mitotic cells following exposure to taxol +  2-AP (right) both have 4N DNA content. Corresponding dot 
plots of MPM-2 signal vs. DNA content (B) show that the MPM-2 signal returns to levels present in untreated interphase cells following 
treatment with taxol  +  2-AP. 
and they can also be distinguished from premitotic cells by 
the presence of micronuclei (Fig. 2). The decrease in MPM-2 
signal is tightly coupled to exit from mitosis, and cells that 
remain in mitosis, as determined by other criteria, fully re- 
tain the MPM-2 signal until the time of mitotic exit (Fig. 2). 
The decrease in MPM-2 signal induced by 2-AP treatment 
can be quantitatively assessed for a population of cells using 
two-dimensional flow cytometry (Fig. 3). Before drug treat- 
ment,  most BHK cells are in  G~  or S  phase  (<4N  DNA 
content)  and  have a  correspondingly low  MPM-2  signal. 
High MPM-2  signal is restricted to the mitotic (4N)  sub- 
population (Fig.  3, A and B, lefi).  A  mitotic population of 
cells, obtained by 5 pg/mi taxol arrest and selective detach- 
ment, has a 4N DNA content and displays a strongly elevated 
MPM-2 signal (data not shown). This profile is unchanged 
in the continued presence of taxol over a time course of 60 
min (Fig.  3, A and B, middle).  In contrast,  when 2-AP is 
added to taxol arrested cells after selective detachment, the 
MPM-2 signal has returned to interphase levels by 60 min 
(Fig. 3 B, right). The DNA content of the 2-AP-treated cells 
remains  4N  (Fig.  3  A,  right),  indicating  that  checkpoint 
override and exit from mitosis have occurred without cell di- 
vision. 
The observation that taxol-treated cells exhibit a greater 
rate of mitotic exit than nocodazole-treated cells suggests 
that mitotic exit is dependent upon the microtubule assembly 
state, since taxol causes nearly complete microtubule assem- 
bly (Schiff and Horwitz, 1980), whereas nocodazole inhibits 
microtubule assembly (Jordan et al.,  1992). To further test 
the relationship between the microtubule assembly state and 
the ability of a cell to exit mitosis, populations of BHK cells 
were arrested in mitosis over a range of nocodazole concen- 
trations (Fig. 4). From the data it is clear that 2-AP induced 
exit from mitosis is most rapid and complete for cells ar- 
rested with the lowest concentration (0.04 #g/ml) of nocoda- 
zole. A partial exit is obtained after 75 min of  2-AP treatment 
in cells arrested with 0.08 #g/ml nocodazole, and no mitotic 
exit is detected through 75 min of 2-AP treatment of cells ar- 
rested with nocodazole at concentrations ranging between 
0.12-1.0 #g/rnl. We conclude that 2-AP-induced mitotic exit 
is highly dependent on the microtubule assembly state. 
We next made an analysis of the extent and sites of micro- 
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Figure 4. Nocodazole concentration influences the ability of 2-AP 
to induce override of mitotic arrest. BHK cells were accumulated 
in mitosis by 10 h treatment with nocodazx)le  at concentrations 
ranging from 0.04-1.00 ttg/ml. The resulting mitotic indices of the 
different populations were indistinguishable. At t = 0, 10 mM 2-AP 
was added to each cell population,  while cells continued to be 
maintained in nocodazole at the same concentration as during the 
accumulation phase of the experiment. The mitotic index was de- 
termined by MPM-2 immunofluorescence assay and by the state of 
DNA condensation (propidium iodide stain). All points represent 
an average of three counts of greater than 150 cells each, and all 
standard deviations were less than 2.5% of the ordinate value. 
tubule  assembly  in mitotic ceils during  the various drug 
treatments, as determined by immunofluorescence micros- 
copy  with  anti-tubulin  antibodies  (Fig.  5).  Mitotic  cells 
treated with 5/~g/mi taxol have multiple dense, highly fluo- 
rescent microtubule asters, around which chromosomes are 
clustered. An interphase cell (Fig. 5, inset) displays periph- 
eral bundles of microtubules, giving evidence of the abnor- 
mal taxol-induced microtubule bundles typically present in 
interphase cells. 
By immunofluorescence microscopy (Fig. 5), it is evident 
that  total  microtubule  mass  decreases  with  increasing 
nocodazole concentrations. In populations treated with 0.04 
ttg/ml nocodazole for 10 h, mitotic cells have a single large 
centrosomal aster with a distinguishable microtubule array. 
At 0.08/~g/mi nocodazole, microtubules are distributed in a 
mixture of centromeric and centrosomal arrays. Among the 
population of mitotic cells,  some have single centrosomal 
asters and other cells contain multiple small asters with foci 
at centromeres (see Fig. 6 for confirmation of centromeric 
microtubule association). The size of the centrosomal asters 
is diminished at 0.08 #g/mi nocodazole compared with those 
observed at 0.04/zg/ml nocodazole. At nocodazole concen- 
trations of 0.12/zg/mi and 0.20/zg/ml (not shown), mitotic 
cells have large numbers of centromere-associated microtu- 
bole foci. The foci are larger in cells treated with 0.12 txg/ml 
than with 0.20 ~g/mi nocodazole, having the appearance of 
small asters. At the highest nocodazole concentrations that 
were assayed, 0.40 and 1.0 #g/ml (not shown), centrioles are 
the  only  structures  detected with  anti-tubulin  antibodies. 
Note  that  the  centrioles are  not  apparent  at  the  highest 
nocodazole concentration in Fig. 5, as confocal microscope 
settings were optimized to samples treated with 0.04 #g/ml 
nocodazole and kept constant for collection of all images. 
0.04 ..c  Mierotubule fluorescence at the position of chromosomes, 
0.oe,.c  and  the  high  number of microtubule foci found in  cells 
o.12 .oc  treated with:0.08-0.20/~g/ml nocodazole both suggested that 
0.2o ,.c  microtubiile assembly might be nucleated at centromeres un- 
o.4o  ,,¢  der these conditions. This possibility was confirmed using 
1.o0 ,,~  confocal microscopy for analysis of the colocalization of hu- 
man autoimmune anti-centromere antibodies (patient JD) 
and anti-tubulin antibodies (Fig. 6). As shown, in cells ex- 
posed to these nocodazole concentrations, multiple centro- 
meres  are  frequently associated  with  single  microtubule 
foci. The apparent coassociation of centromeres and micro- 
tubules was further confirmed by digital image overlay (data 
not shown). Centromeres appear in small clusters which are 
independent of the two centrosomes, as confirmed by dou- 
ble-label  immunofluorescence microscopy with  3,-tubulin 
antibody (data not shown). 
The immunofluorescent analysis, as summarized in Fig. 5, 
suggested that efficient exit from mitosis might require the 
presence of  a centrosomal aster of  microtubules. Exit did not 
occur after 75 rain of 2-AP treatment in those cells which 
contained only centromeric microtubules (0.12-0.20/zg/mi 
nocodazole; Fig. 4). Most interestingly, in cells exposed to 
a condition where partial exit is observed (0.08 #g/mi noco- 
dazole), the initial population consists of a mixture of cells 
in  which  there  are  either  centromere or centrosome as- 
sociated microtubules (Fig. 5), but the cells remaining in mi- 
tosis after 75 min of treatment are exclusively those with 
only centromere-associated microtubules (data not shown). 
From our evidence, induction of mitotic exit minimally re- 
quires a critical mass of microtubules, but it is possible that 
exit further requires the specific interaction of  these microtu- 
bules with the centrosomes of the mitotic cell. 
Initiation of mitosis  requires  activation of p34  ~2  (Lee 
and Nurse,  1987;  Murray et al.,  1989) and p34  cdc2 is nor- 
mally inactivated during exit from mitosis (Murray et al., 
1989; Hunt et al.,  1992). As a further confirmation of the 
progression of mitotic exit following 2-AP addition, we thus 
assayed p34  ~2  kinase  activity during  mitotic  checkpoint 
override induced by 2-AP.  To determine p34  ~2 activity we 
performed a radiolabel assay of histone H1 phosphorylation 
by p34  ~2 immunoprecipitates. The specificity of the assay 
was verified by the absence of H1 kinase activity in immuno- 
precipitate complexes lacking p34  ~2 antibody, and by the 
greater p34  ~2 activity in mitotic extracts as compared to 
extracts from S-phase arrested cells (Fig. 7 A). 
Our results show that p34  ~  activity dramatically declines 
within 15 rain following 2-AP addition to cells arrested in 
mitosis with taxol (Fig. 7 B). In contrast, cells continually 
arrested with taxol alone maintain high levels of p34  cdc2 ac- 
tivity over a period of sixty min (Fig. 7 B). Cells arrested 
with 0.40/~g/ml nocodazole, sufficient to fully depolymerize 
microtubules (Fig. 5), and then co-treated with 2-AP also 
show no decline in p34  ~2 protein kinase activity over 60 
min (Fig. 7 B). At the intermediate nocodazole concentra- 
tion of 0.04 #g/ml, 2-AP addition induces an intermediate 
decrease in p34  ~dc2 activity (Fig. 7 B).  These results dem- 
onstrate that p34  cac2 kinase activity decreases during mitotic 
checkpoint override induced by 2-AP, as occurs during a nor- 
mal mitotic exit, and that the down regulation of p34  cd:2 ac- 
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state. 
The Correlation of  p34  cat2 Localization with Mitotic Exit 
The inactivation of p34  cdc2 is required for exit from mitosis, 
Figure 5.  The site and extent 
of mitotic microtubule assem- 
bly varies with the conditions 
of drug  treatment.  Microtu- 
bule structures were detected 
by  immunofluorescence  mi- 
croscopy using anti-/3-tubulin 
antibodies  and  FITC-goat 
anti-mouse  IgG  secondary 
antibodies (left). Confocal mi- 
croscope  settings  were  op- 
timized  within  the  linear 
range for samples exposed to 
0.04  ttg/ml  nocodazole  and 
were kept constant for the col- 
lection of all images. Condi- 
tions  of decreasing microtu- 
bule assembly (taxol, and then 
increasing  nocodazole  con- 
centrations)  are  shown  by 
descending  order  in  the 
figure.  A  taxol treated inter- 
phase cell (taxol, inset) is in- 
eluded to show the high level 
of microtubule assembly and 
bundling induced by this taxol 
concentration. Chromatin po- 
sition is shown by propidium 
iodide  staining  (right).  Bar, 
20 #m. 
and p34  cdc2 has been demonstrated to be partially localized 
to the mitotic apparatus during mitosis (Bailly et al.,  1989; 
Riabowol  et  al.,  1989;  Alfa et  al.,  1990;  Rattner  et  al., 
1990).  It was therefore important to test whether p34  cdc2 lo- 
calization to the mitotic apparatus correlates with inactiva- 
The Journal of Cell Biology,  Volume 127, 1994  794 Figure 6.  Microtubule structures colocalize with centromeres in 
cells treated with intermediate  concentrations of nocodazole. Mi- 
totic BHK cells  arrested  with 0.08-0.20 #g/ml nocodazole have 
multiple microtubule foci, as shown here at 0.12/~g/ml nocodazole. 
Colocalization with centromeres was tested by digital  overlay  of 
double-label immunofluorescent  images processed with antibodies 
recognizing  centromeres  (human  anti-centromere  serum)  and 
microtubules  (anti-tubulin  antibodies)  and  collected  by  com- 
puter-assisted  confocal microscopy.  For the purpose of demon- 
strating  colocalization, an optical section including  only a subset 
of the centromeres and microtubnle loci is presented here. Primary 
antibodies  were  detected  with  FITC-goat  anti-human  IgG 
(anti-centromere) and Texas Red sheep anti-mouse (anti-tubulin) 
secondary antibodies.  Bar,  5 t~m. 
tion of p34  ~a and exit from mitosis in different microtubule 
assembly states. We therefore conducted an immunofluores- 
cence  analysis  of the  presence  of p34  c~2  on microtubules 
under conditions where cells can or can not be induced to 
exit mitosis with 2-AP. 
The p34  ~-2 antibody used in this study was raised against 
a  COOH-terminal  peptide  of  p34  ~2  (Litchfield  et  al., 
1991).  On immunoblots of whole cell extracts,  p34  cd°2 was 
specifically  recognized  by  the  anti-p34  "da  antibody,  and 
preimmune serum gave no reaction (Fig.  8 A). In intact mi- 
totic  cells  p34  ~2  is  distributed  throughout the cytoplasm, 
but is concentrated on microtubules at drug concentrations 
where  microtubules  persist  (data  not shown).  To enhance 
visualization  of p34  '~°2 within  the  mitotic  apparatus,  cells 
were  prepared  for  immunofluorescence  by  extraction  in 
microtubule  stabilizing buffer before fixation (Fig.  8 B). 
Immunofluorescence microscopy of taxol-treated cells re- 
veals that p34  cd¢2 is concentrated on microtubule asters and 
that p34  °de2 is also clearly present as an abundant signal at 
centromeres  and at the centrosome (Fig.  8  B).  In mitotic 
cells blocked with 0.04/,g/ml nocodazole, p34  c~2 is present 
on microtubules,  centromeres,  and centrosomes, but has a 
lower apparent abundance on microtubules.  At nocodazole 
concentrations sufficient to maintain mitotic arrest in 2-AP 
(0.12  and  1.0/zg/ml),  p34  ~a  remains  associated  with cen- 
tromeres  and the centrosome,  but,  as  demonstrated  by an 
anti-tubulin antibody counterstain, one finds minimal micro- 
tubule arrays and minimal association of p34  cd~ with micro- 
tubules  at  these  nocodazole  concentrations.  Centromeric 
localization of p34  c~2 in mitotic cells was confirmed by cor- 
respondence  of p34  cd~2 with  centromeric  antigens  recog- 
nized by human autoimmune anti-centromere serum (Fig. 8 
C).  The  bright  central  p34  ~.2  signal  that  does  not  cor- 
Figure  7.  p34  '~2  is  inactivated  during  mitotic  exit  induced  by 
2-AP. The protein kinase  activity of p34  ed¢2 was determined by 
radiolabel  assay  of  histone  HI  phosphorylation.  To  assure 
specificity  of the kinase activity,  the assay used p34  cdc2 immuno- 
precipitated  from lysed cell extracts.  The specificity of the assay is 
shown in A. Activity is greater for mitotic cells (NOC) than for S 
phase cells (arrested  with 2 mM hydroxyurea; HU). Activity is not 
detected  in protein from nocodazole-synchronized mitotic extracts 
processed as usual, but without p34  ~2 primary antibodies,  p34  c~2 
HI kinase activity was determined at timepoints for mitotically syn- 
chronized cells,  either with or without exposure to 10 mM 2-AP 
(B).  Ceils were treated with either 5  t~g/ml taxol,  or with 0.04 
t~g/ml or 0.40 #g/ml nocodazole for 10 h before the addition of 10 
mM 2-AP. Time 0 represents  the time of addition  of 2-AP at~er 
10 h of mitotic arrest.  Times shown are elapsed times (in minutes) 
between 2-AP addition and cell lysis for the preparation of  extracts. 
HI kinase  activity  is diminished  under conditions of mitotic exit 
(TAXOL  + 2-AP; or 0.04 #glml NOC + 2-AP ), but is retained dur- 
ing 60 min of continued mitotic arrest (TAXOL, or 0.40 #g/ml NOC 
+  2-AP). 
respond to centromere signal represents p34  c~2 localized to 
the centrosome (see Fig.  8 B). 
The p34  '~°2 localization was cross-checked with a  second 
rabbit anti-p34  c~2 serum (designation  1524), which gave an 
identical  localization  pattern.  The  pre-immune  serum  for 
Andreassen and Margolis Microtubule Dependency of Mitotic Exit  795 Figure 8. Localization of p34  '~c2 during mitosis under various conditions of drug treatment. (A) p34  ~2 is specifically recognized in whole 
cell lysates by 1419 anti-p34  '~2 antibodies (Litchfield et al., 1991), but not by pre-immune serum at the same dilution (/eft), on immuno- 
blots. (B) Double-label immunofluorescence for p34  c'~2 (left) and tubulin (right). Fluorescence analysis was performed using FITC-goat 
anti-rabbit IgG and Texas Red sheep anti-mouse IgG secondary antibodies, respectively, p34  cdc2 is present at centrosomes and centro- 
meres under all conditions shown, and on microtubules when significant microtubule mass is present (taxol and 0.04 #g/ml nocodazole). 
The p34  ¢dc2 staining pattern is not due to signal cross-over, and was obtained whether anti-tubulin  antibody was present or not. (C) Dou- 
ble label immunofluorescence for p34  °a¢2 (left) and anti-centromere  antiserum (right) is shown for a mitotic cell arrested with 0.04/zg/ml 
nocodazole. Bar, 5 #m. 
both  antibodies  gave only  a  background  signal  (data  not 
shown). 
These results show a consistent pattern of correlation be- 
tween  p34  cdc2 association  with  centrosomal  microtubules 
and the capacity of cells to exit mitosis. We conclude that 
efficient  exit  from  mitosis  occurs  only  under  conditions 
where p34  cd¢2 is found associated with centrosomal micro- 
tubules. 
Mitotic Slippage Is Microtubule Dependent 
Mitotic slippage is the natural failure of rodent cells to main- 
tain mitotic arrest during long-term exposure to drugs that 
interfere with either microtubule dynamics or with forma- 
tion of the mitotic spindle (Kung et al.,  1990). Mitotic slip- 
page and mitotic checkpoint override induced by 2-AP both 
involve the  inactivation of p34  ¢*~ and occur without com- 
pletion of late events in mitosis, including cytokinesis. The 
parallels between mitotic slippage and 2-AP-induced check- 
point override led us to consider whether mitotic slippage is 
also microtubule dependent in BHK cells. 
Subconfluent populations of cells were treated with taxol 
or various concentrations of nocodazole and the mitotic in- 
dex was determined at timepoints by scoring for the percent- 
age of MPM-2-positive cells (Fig.  9).  During the first 9 h 
of drug treatment, the mitotic index increases equivalently 
for all cell populations,  regardless of whether treatment is 
with 5 #g/ml taxol, or with 0.04, 0.20, or 1.0 #g/ml nocoda- 
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Figure 9. Mitotic slippage is dependent on the level of microtubule 
assembly. Beginning at t = 0, BHK cells were incubated in medium 
containing either taxol (5/zg/ml)  or nocodazole at 0.04, 0.20, or 
1.00/~g/ml. Cells were fixed at timepoints and prepared for im- 
munofluorescence labeling with MPM-2  antibody and counter- 
stained with propidium iodide. The mitotic index, scored on the 
basis of cells positive for MPM-2 and containing condensed chro- 
mosomes, rises uniformly for all populations through 12 h of drug 
treatment, but then declines in populations treated with taxol or 
0.04 ttg/ml nocodazole. All points represent an average of three 
counts of greater than 150 cells each, and no point has a standard 
deviation of more than 3.0%. 
zole. No midbodies are detected by immunofluorescence mi- 
croscopy  with  anti-tubulin  antibodies  (data  not  shown), 
providing evidence that mitotic progression is blocked at 
each of the drug conditions. 
After treatment for times in excess of  nine hours, the num- 
ber of cells blocked in mitosis begins to diverge in the differ- 
ent drug treatments.  Cells treated with 0.20 or  1.0 #g/ml 
nocodazole continue to accumulate linearly in mitosis, until 
>90% of the cells are in mitosis after 18 h of treatment. At 
these high drug concentrations, the mitotic index remains 
>90% through 21 h of  total treatment. In contrast, after 12 h 
of drug  treatment  the  mitotic  index  no  longer  increases 
linearly for populations arrested with taxol or 0.04 #g/ml 
nocodazole. The taxol and 0.04 #g/ml treated populations 
reach maximal mitotic indices of 60 and 70% after 12 and 
15 h of treatment, respectively. Their mitotic indices then 
decline to less than 25% after 21  h of treatment (Fig. 9). 
Treatment with 0.08 t~g/ml nocodazole yields intermediate 
levels of mitotic slippage, while treatment with 0.12 #g/ml 
nocodazole yields the same result as with 0.20 or 1.0/~g/ml 
nocodazole (data not shown). From these results it is evident 
that, as for 2-AP-induced exit from mitosis, mitotic slippage 
is microtubule dependent and  occurs more readily under 
conditions of full microtubule assembly or in the presence 
of centrosomal microtubule asters. 
The  mitotic  index  curves  were  generated  by  immu- 
nofluorescence microscopy of the mitosis specific antigen 
MPM-2.  The microscopic images themselves clearly dem- 
onstrate that over the first 12 h a striking increase in MPM-2 
reactivity correlates  with  duration  of either taxol  or  1.0 
#g/ml nocodazole drug treatment (Fig. 10). The mitotic in- 
dex is low in both populations before drug treatment, and 
cells are mononucleate. After 12 h of treatment, an increase 
in the incidence of MPM-2-positive cells is evident in both 
populations. Similar to the distribution of p34  ~c2, MPM-2 
reactivity is present at the centrosomes, centromeres, and 
microtubules. Association of MPM-2 epitopes with microtu- 
bules is most apparent in taxol treated ceils. However, after 
21  h  of drug arrest the population treated with  1.0 ttg/ml 
nocodazole is predominantly MPM-2 positive, whereas the 
population treated with taxol is predominantly negative for 
MPM-2. Those ceils treated with high nocodazole that are 
MPM-2  positive  also  contain  condensed  chromosomes, 
while most of  the taxol treated cells are highly multinucleate 
after 21 h of treatment. Micronucleation is a reliable marker 
for aberrant exit from mitotic arrest by mitotic slippage dur- 
ing taxol treatment, just as  for 2-AP-induced checkpoint 
override and mitotic exit (Fig. 2). 
We have also  used two-dimensional flow cytometry to 
confirm the  microtubule dependency of mitotic  slippage 
(Fig.  11), comparing DNA content and MPM-2 signals at 
timepoints for cells treated with either 0.04 or 1.00/zg/ml 
nocodazole. Before drug treatment, the cell population pre- 
dominantly has a 2N DNA content. By flow cytometric as- 
say, the mitotic population is distinguished by its 4N DNA 
content and elevated MPM-2 signal. After 7 h of drug treat- 
ment, about one-half of the treated population has 4N DNA 
content and a corresponding elevation of MPM-2 signal. By 
12 h, most of the cells have 4N DNA content and display 
high  MPM-2  levels.  Populations treated with 0.04 or  1.0 
/xg/ml nocodazole are indistinguishable by these cytometry 
parameters after 7 and 12 h of  drug treatment, indicating that 
significant mitotic slippage does not occur during the first 
12 h  of  drug  treatment.  As  also  demonstrated  by  im- 
munofluorescence analysis, after 21 h of treatment with 1.0 
/~g/ml nocodazole the cell population is almost entirely mi- 
totic, exhibiting a 4N DNA content and an elevated MPM-2 
signal. It is interesting that, even at high nocodazole levels, 
the average MPM-2 signal declines during prolonged mitotic 
arrest. In contrast, ceils treated with 0.04 i~g/ml nocodazole 
have background levels of MPM-2 signal by 21 h of treat- 
ment, consistent with exit from mitosis. 
Mitotic slippage is evident in the population treated with 
0.04/zg/ml nocodazole. The DNA content of this population 
is  4N  or  greater,  as  cells  that  have  exited  mitosis  have 
reinitiated DNA synthesis during the subsequent S phase. 
Few  of  these  cells  have  less  than  4N  DNA  content, 
confirming that they have exited mitosis without the comple- 
tion of cytokinesis. Despite slippage back into interphase 
without completing any of the normal mitotic processes, 
these cells are competent to initiate DNA synthesis in the 
next interphase. 
We conclude that both mitotic slippage and 2-AP induced 
exit from mitosis give evidence of common microtubule- 
dependent mechanisms by which cells control the inactiva- 
tion of p34  cdc2, and thereby reenter interphase. 
Discussion 
Microtubule Dependency of 2-AP-induced Exit 
from Mitosis 
p34  ~c2 protein kinase is central to the regulation of mitosis 
in eukaryotes (Nurse, 1990; Norbury and Nurse, 1992). In- 
activation of p34  ~c2 is required for mitotic exit (Murray et 
al'.,  1989; Ghiara et al., 1991; Gallant and Nigg, 1992), and 
Andreassen and Margolis Microtubule Dependency of Mitotic Exit  797 Figure 10. MPM-2 signal is attenuated and nuclei reform during mitotic slippage of cells treated with taxol. Taxol treated cells undergo 
mitotic slippage. In contrast, cells treated with 1.0 #g/ml nocodazole continue to accumulate in mitosis through 21 h, as demonstrated 
both by MPM-2 antibody reactivity and by the presence of condensed chromosomes (PROPIDIUMIODIDE). BHK cells were fixed prior 
to drug treatment (0 H) or at 12 or 21 h following the addition of 5 ~g/ml taxol or 1.0/~g/ml nocodazole to the culture medium. Samples 
were then prepared for immunofluorescence  analysis with MPM-2 antibodies, and were counter-stained with propidium iodide. MPM-2 
antibodies were detected with FITC-goat anti-mouse IgG secondary antibodies. Bar, 25/~m. 
its  continued activity can maintain the cell  in the mitotic 
state for a prolonged period until certain conditions are met 
for mitotic exit.  These conditions, which act as checkpoints 
to the completion of mitosis, include the assembly of a mi- 
totic  spindle  (Hoyt et  al.,  1991;  Li  and  Murray,  1991), 
microtubule attachment to centromeres (Zirkle, 1970), cen- 
tromere  function  (Tomkiel  et  al.,  1994),  and  the  proper 
alignment of chromosomes at the metaphase position (Zir- 
kle,  1970;  Rieder and Alexander,  1990). 
We have demonstrated that mammalian cells are induced 
to inactivate the p34  cdc2 kinase and to exit mitosis by addi- 
tion of the protein kinase inhibitor 2-AP, but only if a critical 
assembly state of microtubules exists in the cell. The rate of 
2-AP-induced exit from a mitotic block is most rapid in the 
presence of taxol, a mitotic inhibitor which induces an inap- 
propriately high level of microtubule assembly. In contrast, 
increasing nocodazole concentrations decrease the capacity 
for mitotic exit. 2-AP-induced exit from mitosis thus reveals 
an intrinsic role for microtubules in control of  mitotic check- 
points in BHK cells, independent of their mechanical role in 
chromosome segregation. These conclusions are also sup- 
ported by our demonstration that exit from mitosis due to 
mitotic "slippage"  is dependent on the presence of a critical 
level  of microtubule assembly. 
Both the microtubule mass and the localization of  microtu- 
bules in the cell are altered by nocodazole in a concentration 
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Figure  11.  Mitotic slippage analysis by flow cytometry.  Flow cytometry was used to assay both the attenuation of MPM-2 signal and the 
resumption of DNA synthesis during mitotic slippage. DNA content histograms are shown (A) for samples before drug addition or following 
the addition of 0.04 #g/ml (front) or 1.00 #g/ml (back) nocodazole to the culture medium for the times indicated.  Dot plots of MPM-2 
antibody fluorescence signal vs. DNA content (propidium iodide) are shown in B. Accumulation  in mitosis is identical through 12 h treat- 
ment, but cells treated with 0.04 t~g/ml nocodazole undergo mitotic slippage and progress toward 8N DNA content with low MPM-2 signal 
by 21  h. 
dependent manner. At nocodazole concentrations where 2-AP 
induces  mitotic  exit  (0.04-0.08  pg/ml),  microtubules  are 
present as a single aster centered on the centrosome. In con- 
trast,  at 0.12-0.20  pg/ml  nocodazole,  2-AP  cannot induce 
mitotic exit, and in this case microtubules have no apparent 
centrosome  association  but  are  instead  clearly  associated 
with kinetochores. These results suggest that mitotic exit in- 
duced in response to 2-AP may involve centrosomal control, 
mediated  through centrosome-associated  microtubules. 
The microtubule dependency of mitotic exit demonstrates 
that p34  ~z inactivation must be coupled in some important 
manner  to  the  mitotic  spindle.  Such  spindle-associated 
mechanisms might routinely function to assure that a normal 
mitotic spindle is present,  thereby increasing the fidelity of 
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well and Weinert,  1989;  Li and Murray, 1991). 
Our results suggest that efficient checkpoint regulation of 
p34  cdc2 might require the localization of p34  cdc2 and cyclin B 
to the mitotic spindle.  Indeed,  we find that a  portion of 
p34  cd¢2 is localized to spindle microtubules, and to the cen- 
trosome and kinetochores, and that induction of mitotic exit 
by 2-AP occurs only under conditions where p34  ~dc2 is as- 
sociated with astral microtubules. Other recent studies have 
suggested that the active form of p34  ~d~2 is concentrated at 
the mitotic spindle  (Tombes  et al.,  1991; Kubiak et al., 
1993),  and Edgar et al. (1994) have recently suggested that 
the mitotic spindle may be the site of local degradation of cy- 
clin B during exit from mitosis in early Drosophila embryos. 
It is important, in'this regard, to note that several molecu- 
lar elements implicated in the control of cyclin B degradation 
are localized to the mitotic spindle. Calmodulin-dependent 
protein kinase II, which modulates cyclin B degradation and 
exit from meiotic arrest in Xenopus oocytes (Lorca et al., 
1993) is present on the mitotic spindle (Ohta et al.,  1990). 
Ca2+/calmodulin  (Welsh  et  al.,  1979),  which  regulates 
calmodulin-dependent protein kinase II, and is critical to the 
regulation of mitotic exit in yeast, Xenopus, and mammalian 
cells (Rasmussen and Means,  1989) is also present on the 
mitotic spindle. Additionally, elements directly involved in 
cyclin B destruction are concentrated on the mitotic spindle. 
These include ubiquitin (Murti et al., 1988), which becomes 
conjugated to cyclin B to signal its destruction (Glotzer et 
al., 1991), and the 20S proteasome core of the 26S protease 
complex (Amsterdam et al., 1993) which is implicated in the 
degradation of ubiquitinated cyclin (Ghislain et al.,  1993; 
Gordon et al.,  1993;  Hersko and Ciechanover, 1992). 
While it is evident that efficient checkpoint override of mi- 
totic arrest in BHK cells requires spindle microtubules, the 
effect is not absolute. In the experiments reported here, 2-AP 
induced exit and exit through "slippage" will eventually occur 
in the absence of  detectable microtubules. Further, it appears 
that various cell types have differences in the mechanism of 
M phase arrest. At an extreme, drug disassembly of  microtu- 
bules does not induce cell cycle arrest in Xenopus embryos 
before the mid-blastula transition (Gerhart et al.,  1984). 
It has recently been reported that cyclin B degradation is 
microtubule  dependent  during  the  metaphase-anaphase 
transition in meiotic mouse oocytes (Kubiak et al.,  1993). 
The mouse oocyte observations, together with our results, 
give evidence that microtubule dependent signals are impor- 
tant to cell cycle progression in both meiotic and mitotic 
mammalian cells. There is, however, an important difference 
between meiotic and mitotic control mechanisms. C-mos 
protein kinase is specifically required to maintain prolonged 
meiotic arrest in a variety of organisms including Xenopus 
(Sagata et al.,  1989) and mice (OqKeefe et al.,  1991), and, 
under the influence of c-mos, the meiotic cell remains ar- 
rested in a metaphase configuration with a fully assembled 
spindle  until  the  oocyte is  fertilized.  C-mos  is  meiosis 
specific, and is not involved in maintenance of mitotic cells 
in metaphase (Mutter and Wolgemuth, 1987; Herzog et al., 
1988). 
Implications  for the 2-AP Mechanism of  Action 
The microtubule dependency of mitotic exit also has impor- 
tant implications for the mechanism of action of 2-AP in in- 
ducing checkpoint override. It has been reported that 2-AP 
acts as a protein kinase inhibitor (FarreU et al.,  1977) and 
that it has a highly selective effect on the pattern of protein 
phosphorylation in intact cells (Mahadevan et al., 1990). If 
2-AP causes checkpoint override and mitotic exit by sup- 
pressing a protein kinase activity, it is certain that 2-AP does 
not act by directly suppressing the activity of p34  ~d~2. If that 
were the case, all cells arrested in mitosis would exit upon 
addition of 2-AP, regardless of the microtubule assembly 
state. This interpretation was also implied in our previous 
results (Andreassen and Margolis, 1992) which showed that 
2-AP dependent override of interphase checkpoints advances 
cells forward into mitosis. 
Microtubule Assembly from Kinetochores 
The association of microtubules with kinetochores at inter- 
mediate nocodazole concentrations suggests  that microtu- 
bules are capable of nucleating at kinetochores under ap- 
propriate  in  vivo conditions.  Kinetochore nucleation has 
previously been reported in mammalian tissue culture cells 
recovering from colcemid treatment (Witt et al., 1980). We 
have suggested that kinetochore-dependent microtubule as- 
sembly may have a part in the maintenance of the normal 
microtubule steady state, and mitotic spindle function (Mar- 
golis and Wilson, 1981; Garel et al.,  1987).  Furthermore, 
proximal assembly of microtubules at kinetochores is im- 
plicit in the observed metaphase and anaphase poleward flux 
of kinetochore microtubules (Mitchison,  1989;  Mitchison 
and Salmon, 1992). It is interesting to note that microtubules 
seeded from kinetochores must have a greater stability than 
those seeded from centrosomes, since they alone persist at 
the  appropriate  nocodazole concentrations.  This  stability 
may relate to microtubule stabilizing factors that associate 
specifically with kinetochore microtubules (Margolis et al., 
1990). 
Mitotic Slippage Is Microtubule Dependent 
During mitotic slippage, cyclin B is degraded and p34  ~dc2 is 
inactivated as ceils escape mitotic blockage and resume in- 
terphase (Kung et al., 1990). In BHK cells, we find that the 
rate of mitotic slippage is highly dependent on the level of 
microtubule assembly in the arrested cell. We have shown 
that the rate of entry into mitosis is not influenced by either 
the nature or concentration of the pharmacological reagent 
utilized to interfere with microtubule function, but that the 
rate of mitotic exit through slippage increases with the level 
of microtubule assembly. Therefore, as with 2-AP-induced 
exit from mitotic arrest, mitotic slippage appears to depend 
upon the presence of microtubules for the inactivation of 
p34cdc2. 
There are many similarities between mitotic slippage and 
mitotic checkpoint override induced by 2-AP. Both processes 
are dependent on the level of microtubule assembly, involve 
inactivation of p34  ~c2, and occur without chromosome seg- 
regation or cell division. But while 2-AP induces a rapid exit 
from mitosis, presumably through inhibition of a protein ki- 
nase essential to maintenance of the mitotic state (Andreas- 
sen and Margolis, 1991), mitotic slippage occurs gradually 
because of the inability of the cell to indefinitely maintain 
cyclin B and active p34  cd'2 (Kung et al.,  1990). 
The involvement of microtubule assembly state in the con- 
The Journal of Cell Biology, Volume  127, 1994  800 trol of mitotic slippage may have implications for tumor che- 
motherapy.  Inhibitors  of microtubule dynamics,  including 
vinblastine, vincristine, and taxol, have been used in chemo- 
therapy for a variety of human tumors (Rowinsky and Done- 
hower, 1991).  It is unknown if optimal cell killing occurs as 
a result of sustained mitotic arrest or as a result of mitotic 
slippage. Such information should make it possible to more 
rationally determine the most effective doses for pharmaco- 
logical agents  that act on the microtubule assembly state. 
We have presented evidence that the ability to override mi- 
totic arrest is sensitive to the level of microtubule assembly 
in mammalian cells.  We conclude from these studies that 
microtubules play an important role in the control of mitotic 
exit. Effects of the microtubule assembly state on cell cycle 
progression during interphase have also been reported. For 
example,  microtubule  depolymerization  stimulates  DNA 
replication in serum starved fibroblasts (Crossin and Carney, 
1981),  and can enhance the response of Go cells to growth 
factors (McClain and Edelman, 1980). We are presently un- 
dertaking  an analysis to determine whether the microtubule 
assembly  state  may  play  a  general  role in the  control of 
progression at various phases of the cell cycle. 
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